Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 0

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Improvement of classical therapy in EGFR inhibitors-induced cutaneous adverse reaction by microneedle delivery and Astragalus polysaccharide

Zhang, Luzheng, Zhang, Jie, Chen, Yiwen, Hou, Ping, Zhou, Zihan, Ding, Zifan, Jia, Bei, Xu, Runbing, Jiang, Miao, Yan, Cong·2025·International Journal of Biological Macromolecules
DOI 10.1016/j.ijbiomac.2025.140762
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijbiomac.2025.140762

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 29

  1. Lacouture, 2006, Mechanisms of cutaneous toxicities to egfr inhibitors, Nat. Rev. Cancer, 6, 803, 10.1038/nrc1970 · DOI · Paper page
  2. Tsuboi, 2023, Overall survival with osimertinib in resected egfr-mutated nsclc, N. Engl. J. Med., 389, 137, 10.1056/NEJMoa2304594 · DOI · Paper page
  3. Ayati, 2020, A review on progression of epidermal growth factor receptor (egfr) inhibitors as an efficient approach in cancer targeted therapy, Bioorg. Chem., 99, 10.1016/j.bioorg.2020.103811 · DOI · Paper page
  4. Zhao, 2022, Global research trends on precision cancer medicine-related rashes (2008-2021): a bibliographic study, Front. Immunol., 13
  5. Kim, 2020, Rhegf treatment improves egfr inhibitor-induced skin barrier and immune defects, Cancers, 12, 10.3390/cancers12113120 · DOI
  6. Ochsendorf, 2010, Minocycline in acne vulgaris benefits and risks, Am. J. Clin. Dermatol., 11, 327, 10.2165/11319280-000000000-00000 · DOI
  7. Lacouture, 2021, Reducing skin toxicities from egfr inhibitors with topical braf inhibitor therapy, Cancer Discov., 11, 2158, 10.1158/2159-8290.CD-20-1847 · DOI
  8. Papoui, 2021, The extent to which the last decade has yielded additional treatment options for egfr-associated rash besides classic treatment with antibiotics and corticosteroids - a systematic review, Eur. J. Oncol. Nurs., 50, 10.1016/j.ejon.2021.101896 · doi:10.1016/j.ejon.2021.101896
  9. Xu, 2022, Ph-responsive astragalus polysaccharide-loaded plga nanoparticles as an adjuvant system to improve immune responses, Int. J. Biol. Macromol., 222, 1936, 10.1016/j.ijbiomac.2022.09.283 · DOI
  10. Li, 2022, Astragalus polysaccharide: a review of its immunomodulatory effect, Arch. Pharm. Res., 45, 367, 10.1007/s12272-022-01393-3 · doi:10.1007/s12272-022-01393-3
  11. Li, 2020, Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation, Int. J. Biol. Macromol., 145, 985, 10.1016/j.ijbiomac.2019.09.189 · DOI · Paper page
  12. Yu, 2023, Autologous-cancer-cryoablation-mediated nanovaccine augments systematic immunotherapy, Mater. Horiz., 10, 1661, 10.1039/D3MH00092C · DOI
  13. Liu, 2024, Composite microneedles loaded with astragalus membranaceus polysaccharide nanoparticles promote wound healing by curbing the ros/nf-κb pathway to regulate macrophage polarization, Carbohydr. Polym., 345, 10.1016/j.carbpol.2024.122574 · DOI
  14. Phatale, 2022, Overcoming skin barriers through advanced transdermal drug delivery approaches, J. Control. Release, 351, 361, 10.1016/j.jconrel.2022.09.025 · DOI · Paper page
  15. Lyu, 2023, Going below and beyond the surface: microneedle structure, materials, drugs, fabrication, and applications for wound healing and tissue regeneration, Bioact. Mater., 27, 303
  16. Sartawi, 2022, Dissolving microneedles: applications and growing therapeutic potential, J. Control. Release, 348, 186, 10.1016/j.jconrel.2022.05.045 · DOI · Paper page
  17. Lu, 2023, Encoded structural color microneedle patches for multiple screening of wound small molecules, Adv. Mater.
  18. Oh, 2022, Fabrication of a pva-based hydrogel microneedle patch, ACS Omega, 7, 25179, 10.1021/acsomega.2c01993 · DOI
  19. Mangang, 2023, Pvp-microneedle array for drug delivery: mechanical insight, biodegradation, and recent advances, J. Biomater. Sci. Polym. Ed., 34, 986, 10.1080/09205063.2022.2155778 · doi:10.1080/09205063.2022.2155778
  20. Ebrahiminejad, 2022, Microneedle arrays for drug delivery and diagnostics: toward an optimized design, reliable insertion, and penetration, Adv. Mater. Interfaces, 9
  21. Liu, 2023, Multifunctional double-layer and dual drug-loaded microneedle patch promotes diabetic wound healing, Adv. Healthc. Mater.
  22. Zhang, 2023, Traditional chinese medicine formulae qy305 reducing cutaneous adverse reaction and diarrhea by its nanostructure, Adv. Sci.
  23. Zhang, 2021, Comparison of gefitinib-induced skin adverse reactions (sar) in c57bl/6 and fvb/n mice, Toxicol. Res., 10, 334, 10.1093/toxres/tfab008 · DOI
  24. Pastore, 2008, The epidermal growth factor receptor system in skin repair and inflammation, J. Invest. Dermatol., 128, 1365, 10.1038/sj.jid.5701184 · DOI · Paper page
  25. Finkelman, 2023, The evolution of ki-67 and breast carcinoma: past observations, present directions, and future considerations, Cancers, 15, 808, 10.3390/cancers15030808 · DOI
  26. Luo, 2024, The role of natural products from herbal medicine in tlr4 signaling for colorectal cancer treatment, Molecules, 29, 10.3390/molecules29122727 · DOI
  27. Martins, 2021, A review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea, Antibiotics-Basel, 10
  28. Lee, 2016, Hepatotoxicity of targeted therapy for cancer, Expert Opin. Drug Metab. Toxicol., 12, 789, 10.1080/17425255.2016.1190831 · DOI
  29. Jordan, 2017, Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients, Cancer Immunol. Immunother., 66, 503, 10.1007/s00262-016-1953-z · DOI

Metadata

Authors
Zhang, L., Zhang, J., Chen, Y., Hou, P., Zhou, Z., Ding, Z., Jia, B., Xu, R., Jiang, M., & Yan, C.
Venue
International Journal of Biological Macromolecules
Publisher
Elsevier BV
Published
2025-04
Volume
304
Pages
140762
ISSN
0141-8130
DOI
10.1016/j.ijbiomac.2025.140762
Cited by
0
References
1
Language
en
Licence
Funders
  • National Natural Science Foundation of China (82274225, 81973667)
  • Fundamental Research Funds for the Central Universities (2024-JYB-KYPT-06)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improvement of classical therapy in EGFR inhibitors-induced cutaneous adverse reaction by microneedle delivery and Astragalus polysaccharide. https://app.cochat.ai/papers/10.1016/j.ijbiomac.2025.140762
The paper
Zhang, L., Zhang, J., Chen, Y., Hou, P., Zhou, Z., Ding, Z., Jia, B., Xu, R., Jiang, M., & Yan, C. (2025). Improvement of classical therapy in EGFR inhibitors-induced cutaneous adverse reaction by microneedle delivery and Astragalus polysaccharide. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2025.140762

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.